Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient.

Literature DB >> 6150343

Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient.

R S Bonser, D Adu, I Franklin, P McMaster.

Abstract

Entities: Chemical Disease

Mesh：

Substances：
Cyclosporins

Year: 1984 PMID： 6150343 DOI： 10.1016/s0140-6736(84)90842-0

Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321

Keyword Cloud
Cited

× No keyword cloud information.

12 in total

1. Cyclosporin neurotoxicity after chemotherapy. Case had features of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.

Authors: G Pratt; B Kennedy; G Smith
Journal: BMJ Date: 1999-07-03

2. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

Authors: Gema Ariceta; Nesrin Besbas; Sally Johnson; Diana Karpman; Daniel Landau; Christoph Licht; Chantal Loirat; Carmine Pecoraro; C Mark Taylor; Nicole Van de Kar; Johan Vandewalle; Lothar B Zimmerhackl
Journal: Pediatr Nephrol Date: 2008-09-18 Impact factor: 3.714

Review 3. Complications of cyclosporin therapy.

Authors: B D Kahan; S M Flechner; M I Lorber; C Jensen; D Golden; C T Van Buren
Journal: World J Surg Date: 1986-06 Impact factor: 3.352

4. Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat).

Authors: Klilah Hershko; Vijaya L Simhadri; Adam Blaisdell; Ryan C Hunt; Jordan Newell; Sandra C Tseng; Alon Y Hershko; Jae Won Choi; Zuben E Sauna; Andrew Wu; Richard J Bram; Anton A Komar; Chava Kimchi-Sarfaty
Journal: J Biol Chem Date: 2012-11-09 Impact factor: 5.157

Cyclosporin-induced haemolytic uraemic syndrome in liver allograft recipient.

1. Cyclosporin neurotoxicity after chemotherapy. Case had features of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome.

2. Guideline for the investigation and initial therapy of diarrhea-negative hemolytic uremic syndrome.

Review 3. Complications of cyclosporin therapy.

4. Cyclosporin A impairs the secretion and activity of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeat).

Review 5. The pathophysiology of Sandimmune (cyclosporine) in man and animals.

6. Transplant-associated thrombotic microangiopathy in pediatric patients treated with sirolimus and tacrolimus.

7. Post-transplantation outcome of patients with hemolytic-uremic syndrome: update.

8. Morphological differentiation between rejection and cyclosporin nephrotoxicity in renal allografts.

9. Renal transplantation in patients with classical haemolytic-uraemic syndrome.

10. Cyclosporin A and anti-glomerular basement membrane antibody glomerulonephritis in rats.